Saltar al contenido principal
Elsevier

Epigenetic Regulation of Cancer - Part B

  • 1 Edición, Volumen 383 - 13 de febrero de 2024
  • Última edición
  • Editores: Sheila Spada, Lorenzo Galluzzi
  • Idioma: Inglés

Epigenetic Regulation of Cancer, Part B, Volume 383 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume pr… Leer más

Descripción

Epigenetic Regulation of Cancer, Part B, Volume 383 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of hot topics, including Epigenetic control of cell signaling in cancer stem cells, Genetic and epigenetic features of neuroendocrine prostate cancer and their emerging applications, Epigenetic regulation in pancreatic cancer, Epigenome Editing in Cancer: Advances and Challenges for Potential Therapeutic Options, Inhibition of epigenetic mechanisms in cancer, and Epigenetics as a determinant of radiation response in cancer.

Puntos claves

  • Provides the latest information on cancer research
  • Offers outstanding and original reviews on a range of cancer research topics
  • Serves as an indispensable reference for researchers and students alike

De interès para

International Research Community, Industry Professionals, Academic Institutions

Índice

1. Epigenetic control of cell signalling in cancer stem cells
Amitava basu

2. Genetic and epigenetic features of neuroendocrine prostate cancer and their emerging applications
Aniruddha Chatterjee

3. Epigenetic regulation in pancreatic cancer
tamas gonda

4. Epigenome Editing in Cancer: Advances and Challenges for Potential Therapeutic Options
Jungsun Kim, Seung Won Lee and Connor Frankston

5. Inhibition of epigenetic mechanisms in cancer
Ning Wang

6. Epigenetics as a determinant of radiation response in cancer
Elena Arechaga-Ocampo

Detalles del producto

  • Edición: 1
  • Última edición
  • Volumen: 383
  • Publicado: 13 de febrero de 2024
  • Idioma: Inglés

Sobre los editores

SS

Sheila Spada

Sheila Spada is at Weill Cornell Medical College, NY, USA
Afiliaciones y experiencia
Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA

LG

Lorenzo Galluzzi

Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology. Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals: OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience.
Afiliaciones y experiencia
Assistant Professor of Cell Biology in Radiation Oncology, Department of Radiation Oncology, Weill Cornell Medical College, NY, USA

Ver libro en ScienceDirect

Lee Epigenetic Regulation of Cancer - Part B en ScienceDirect